3‐Indoxyl Sulfate and O ‐Acetylcarnitine Are Potential Novel Biomarkers for Early Diagnosis of Esophageal Cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: Esophageal cancer is the seventh most common cancer worldwide, and early detection is crucial for improving long-term survival. However, reliable noninvasive biomarkers for early-stage disease remain limited. In this study, we aimed to identify novel biomarkers for early-stage esophageal cancer through comprehensive metabolomic analyses of plasma and urine samples from patients and healthy individuals. Metabolomic profiling revealed that 3-indoxyl sulfate (3-IS) was consistently elevated in both plasma and urine of esophageal cancer patients. As esophageal cancer cells do not directly produce 3-IS, its elevation may reflect cancer-associated systemic metabolic alterations. O-acetylcarnitine (O-AC) was identified as the most significantly increased metabolite in plasma, and in vitro analyses suggested a possible association with tumor-related metabolic changes. Receiver operating characteristic analyses (ROC) demonstrated that the combined plasma and urinary 3-IS model achieved an area under the curve (AUC) of 0.863 in Stage I/II disease, whereas plasma O-AC achieved an AUC of 0.902. Bootstrap resampling provided internal validation; however, the discovery and evaluation were performed within the same single-center cohort. These results suggest that 3-IS and O-AC are promising candidate biomarkers that distinguish patients with esophageal cancer from healthy individuals, but further validation of their disease specificity and diagnostic performance is required in independent multicenter cohorts including clinically relevant disease-control groups.
Source: Cancer Science
DOI: 10.1111/cas.70570
Institutions: Tohoku University, University of Tsukuba, Juntendo University, Kanagawa Institute of Industrial Science and Technology, Institute for Advanced Biosciences, Keio University, Transborder Medical Research Center, Keio University, Keio University Human Biology-Microbiome-Quantum Research Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,600
OpenAlex ID: W7225731912
